ACA

A Supreme Court case tackling whether the federal government must reimburse health insurers that lost money participating in the Affordable Care Act is worth billions collectively and will be closely watched — but the outcome is unlikely to have a big impact on the insurers’ bottom...

The latest Republican tax reform bill takes yet another stab at the Affordable Care Act with a proposed repeal of individual mandates, party leadership said Tuesday. The mandates had required Americans to either get health insurance or pay a tax, an alternative that incentivized coverage for an...

The Trump Administration’s decision to discontinue Affordable Care Act subsidy payments would have dramatic implications on insurers and consumers alike, according to CIGNA Corporation (NYSE: CI). “Many Americans in the Individual insurance market rely on the federal government’s...

Molina Healthcare, Inc. (NYSE: MOH) is in the process of undergoing an "extreme makeover," according to analysts at Morgan Stanley. The firm's Zack Sopcak upgrades Molina Healthcare's stock rating from Underweight all the way to Overweight with a price target boosted from $65 to $68. Shares of...

Health care, the S&P 500's third-largest sector allocation, is rebounding nicely after slumping in 2016 when the sector notched its first negative showing on an annual basis. This year, the Health Care Select Sector SPDR (NYSE: XLV) is higher by nearly 15 percent. Although the health care...

Despite conceding two party votes to the Democratic opposition, Senate Republicans rallied enough support Tuesday to send the ongoing healthcare debate to the floor for open discussion. The procedural vote was dramatic, tallying multiple last-minute supporters and the critical involvement of Sen....

The drama in Washington surrounding health care reform seems to change on a daily basis, and the most recent maneuver by Senate Majority Leader Mitch McConnell has some Republicans scratching their heads. After Republicans failed to scrape together enough votes to pass the second version of their...

On Thursday, Senate Republicans unveiled their revised healthcare reform bill. Here’s everything you need to know. ‘Skinny’ Policies  The new bill allows insurers to sell “skinny” insurance plans that don’t meet the minimum coverage requirements currently in...

Health care stocks and exchange-traded funds jumped last week as Senate Republicans unveiled legislation that would repeal the Affordable Care Act, also known as "Obamacare." While some health care ETFs cooled on Friday, the PowerShares S&P SmallCap Hlth Cr Ptflo (NASDAQ: PSCH) was one of just...

Republicans in Congress promised to repeal the Affordable Care Act on the first day of a new GOP administration. Five months later, the overhaul remains stalled, just one part of an agenda paralyzed by the probe into President Donald Trump’s dealings with Russia. The U.S. Senate is working on...

It’s going to be busy this week in the healthcare industry, with several key developments on the schedule that could have a major impact on the U.S. healthcare sector. What A Week First, on Monday, the Centers for Medicare and Medicaid Services released the latest batch of Health Insurance...

Height Securities released its latest analysis of the American Health Care Act Friday following the Congressional Budget Office’s scoring report. Height analyst Stefanie Miller believes the CBO’s scoring will not hinder Republican efforts to move the bill through to the President...

The poor, the elderly, the disabled, college students and environmental protections all stand to take a big hit if Congress approves President Donald Trump’s $4.1 trillion budget for fiscal year 2018. Defense contractors, corporations in general and the wealthiest Americans all stand to gain...

Americans and investors hoping for healthcare reform may have the strongest congressional motivator of all on their side: fear. If Congress doesn’t get a healthcare reform law passed by the summer recess, representatives will face the prospect of disgruntled constituents as they hold town...

EXACT Sciences Corporation (NASDAQ: EXAS) plummeted over 7 percent Monday on a Citron Research report predicting a 40-percent short-term value concession and long-term drop to a near-zero single digit. Citron's most important report in YEARS. $EXAS to trade short term $20. Long term much lower...